Zenas BioPharma, Inc. (ZBIO)
25.28
+0.02
(+0.08%)
USD |
NASDAQ |
Mar 06, 16:00
25.32
+0.04
(+0.14%)
Pre-Market: 20:00
Zenas BioPharma EPS Diluted (Quarterly) : -1.222 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| XOMA Royalty Corp. | 0.6991 |
| CorMedix, Inc. | 0.1493 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.50M |
| Total Expenses (Quarterly) | 51.50M |
| Enterprise Value | 767.48M |
| Earnings Yield | -17.92% |
| Normalized Earnings Yield | -17.59 |